Doctors followed standard testing guidelines, which recommend discontinuing screenings for men over 70 years old. Should that change?

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Just ...

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

Despite a lack of level 1 evidence, metastasis-directed therapy has been increasingly used for the treatment of oligometastatic prostate cancer based on findings from several randomized phase II ...

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media coverage raises awareness. More men may seek information or medical advice. We’ve ...

Improving the specificity of prostate cancer treatment requires ligands that bind selectively and with ultra-high affinity to tumour-associated targets absent from healthy tissues. Prostatic acid ...